AL
The startup operates a medical technology platform that utilizes real-time biosensing to continuously monitor kidney function and metabolic health at the bedside. This technology enables clinicians to evaluate organ viability before transplantation and track patient recovery post-transplant, facilitating informed decisions regarding organ suitability and patient care.
Updated 3 months ago
Funding
$910K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a medical technology platform that utilizes real-time biosensing to continuously monitor kidney function and metabolic health at the bedside. This technology enables clinicians to evaluate organ viability before transplantation and track patient recovery post-transplant, facilitating informed decisions regarding organ suitability and patient care.